Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +734.12%
#3 ADO Protocol ADO Protocol +101.66%
#4 Cortex Cortex +93.48%
#5 Ontology Gas Ontology Gas +74.08%
#6 Kinesis Silver Kinesis Silver +53.91%
#7 Magma Finance Magma Finance +27.64%
#8 OpenEden OpenEden +26.06%
#9 PondCoin PondCoin +25.14%
#10 QuantixAI QuantixAI +23.16%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Axcella Health Inc. Axcella Health Inc.

Axcella Health Inc.

AXLA
Rank in Stocks #18693
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused... Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical trials, where it is being evaluated for its potential to lower the risk of recurrent overt hepatic encephalopathy. Meanwhile, AXA1125 is progressing through multiple trials: a Phase 2b study targeting non-alcoholic steatohepatitis (NASH) treatment, and a Phase 2a study exploring its efficacy as a therapy for Long COVID patients. Founded in 2008, the entity initially operated as Newco LS16, Inc. before officially adopting the name Axcella Health Inc. in June 2016. Its operations are headquartered in Cambridge, Massachusetts.
Share Price
$4.58
Last synced: 2025-02-06
Market Cap
$189.73M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Axcella Health Inc. (AXLA)

Category

Healthcare
Earnings for Axcella Health Inc. (AXLA)
Earnings in 2026 TTM: 0
According to Axcella Health Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Axcella Health Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH